These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30784665)

  • 21. Parathyroid hormone suppression by cimetidine in the uremic patient.
    Beehler CJ; Beckner JR; Rosenquist RC; Shankel SW
    Ann Intern Med; 1980 Dec; 93(6):840-1. PubMed ID: 7447192
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of dialysate calcium concentration on plasma parathyroid hormone during hemodialysis.
    McIntosh CH; Fuchs C; Dorn D; Quellhorst E; Henning HV; Hesch RD; Scheler F
    Nephron; 1977; 19(2):88-94. PubMed ID: 887190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Values of intact serum parathyroid hormone in different stages of renal insufficiency.
    Hellman P; Backman U; Danielson BG; Akerström G; Rastad J; Wide L; Ljunghall S
    Scand J Urol Nephrol; 1991; 25(3):227-32. PubMed ID: 1947852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis].
    Bagon J; Brunfaut C
    J Radiol Electrol Med Nucl; 1974 Jan; 55(1):35-9. PubMed ID: 4831994
    [No Abstract]   [Full Text] [Related]  

  • 25. [Extra-osseous calcification and its regression after treatment in a case of long-term hemodialysis].
    Kuhlencordt F; Augustin HJ; Kruse HP
    Dtsch Med Wochenschr; 1970 Oct; 95(42):2122-5. PubMed ID: 4990903
    [No Abstract]   [Full Text] [Related]  

  • 26. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
    Meakins JL; Milne CA; Hollomby DJ; Goltzman D
    Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-evaluating our approach to calcium and phosphorus management in dialysis patients.
    Keith DS
    Am J Kidney Dis; 2001 Jun; 37(6):1331-3. PubMed ID: 11382711
    [No Abstract]   [Full Text] [Related]  

  • 28. Different outcomes following parathyroidectomy in patients with uremic tumoral calcinosis: two case reports.
    Li J; Li X; Dong X; Ma L; Guo Z; Chen X
    BMC Nephrol; 2023 Mar; 24(1):55. PubMed ID: 36922797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis].
    Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G
    Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074
    [No Abstract]   [Full Text] [Related]  

  • 30. [Brown tumors in chronic hemodialysis patients].
    Gorsane I; Zammouri A; El Meddeb J; Younsi F; Bartkiz A; Abdelmoula J; Barbouch S; Ben Abdallah T
    Nephrol Ther; 2016 Apr; 12(2):86-93. PubMed ID: 26907666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis.
    Varghese Z; Moorhead JF; Wills MR
    Lancet; 1973 Nov; 302(7836):985-8. PubMed ID: 4127276
    [No Abstract]   [Full Text] [Related]  

  • 32. Maxillary brown tumor of secondary hyperparathyroidism in a hemodialysis patient.
    Weiss RR; Schoeneman MJ; Primack W; Rozycki D; Bennett B; Greifer I
    JAMA; 1980 May; 243(19):1929-30. PubMed ID: 7365977
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumoral calcinosis in patients on hemodialysis. Case report and review of the literature.
    Pecovnik-Balon B; Kramberger S
    Am J Nephrol; 1997; 17(1):93-5. PubMed ID: 9057960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits.
    Hamada J; Tamai K; Ono W; Saotome K
    J Rheumatol; 2006 Jan; 33(1):119-26. PubMed ID: 16395759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid hormone, calcium and phosphate balance in hemofiltration.
    Fuchs C; Doht B; Dorn D; McIntosh C; Ritter D; Scheler F
    J Dial; 1977; 1(6):631-40. PubMed ID: 608872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcific uraemic arteriolopathy.
    Disbrow MB; Qaqish I; Kransdorf M; Chakkera HA
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26315356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silicon in chronic hemodialysis patients.
    Hosokawa S; Morinaga M; Nishitani H; Maeda T; Yoshida O
    ASAIO Trans; 1987; 33(3):260-4. PubMed ID: 3314921
    [No Abstract]   [Full Text] [Related]  

  • 39. Crystal-induced inflammation associated with chronic renal failure treated with periodic hemodialysis.
    Moskowitz RW; Vertes V; Schwartz A; Marshall G; Friedman B
    Am J Med; 1969 Sep; 47(3):450-60. PubMed ID: 5808658
    [No Abstract]   [Full Text] [Related]  

  • 40. Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: potential role of homocysteine and parathyroid hormone.
    Gade K; Blaschke S; Rodenbeck A; Becker A; Anderson-Schmidt H; Cohrs S
    Kidney Blood Press Res; 2013; 37(4-5):458-63. PubMed ID: 24247595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.